5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione, 97.0%, 10mg

N-(2,4-Dichlorobenzyl)hydroxylamine hydrochloride, 95.0%, 5g

(R)-2-((tert-Butoxycarbonyl)amino)-3-(2,4,5-trifluorophenyl)propanoic acid, 95.0%, 5g

2-Methylquinolin-3-amine, 95.0%, 5g

2,6-Dichloro-9-cyclopentyl-9H-purine, 98%, 100mg

3-(4-Methyl-3-nitro-phenyl)-1H-[1,2,4]triazole, 95.0%, 5g

4-Nitrophenyl butyrate, 95.0%, 5g

Tetrabutylammonium Difluorotriphenylstannate>97.0%(T)5g

4-Bromo-1-trimethylsilyl-1-butyne, 97%, 5g

2-(2-Chlorophenyl)piperazine dihydrochloride, 250mg

Cyclopentane, min. 95%, for synthesis, 500 ml, glass packaging

Ethyl 2-[(2-methoxy-2-oxoethyl)sulfanyl]acetate, 99.0%, 5g

(1S,2R)-2-(((TERT-BUTOXYCARBONYL)AMINO)METHYL)CYCLOPROPANE-1-CARBOXYLIC ACID, 95%, 1g